<?xml version="1.0" encoding="UTF-8"?>
<references>
<reference>
  <a1>Chernyshov P.V.</a1>
  <a2>Tomas-Aragones L.</a2>
  <a2>Finlay A.Y.</a2>
  <a2>Manolache L.</a2>
  <a2>Marron S.E.</a2>
  <a2>Sampogna F.</a2>
  <a2>Spillekom-van Koulil S.</a2>
  <a2>Pustisek N.</a2>
  <a2>Suru A.</a2>
  <a2>Evers A.W.M.</a2>
  <a2>Salavastru C.</a2>
  <a2>Svensson A.</a2>
  <a2>Abeni D.</a2>
  <a2>Blome C.</a2>
  <a2>Poot F.</a2>
  <a2>Jemec G.B.E.</a2>
  <a2>Linder D.</a2>
  <a2>Augustin M.</a2>
  <a2>Bewley A.</a2>
  <a2>Salek S.S.</a2>
  <a2>Szepietowski J.C.</a2>
  <t1>Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes</t1>
  <t2>JEADV, J. Eur. Acad. Dermatol. Venereol.</t2>
  <sn/>
  <op/>
  <vo/>
  <ab/>
  <la>eng</la>
  <k1/>
  <pb/>
  <pp/>
  <yr>2021</yr>
  <ed/>
  <ul>http://zaguan.unizar.es/record/117353/files/texto_completo.pdf;
	http://zaguan.unizar.es/record/117353/files/texto_completo.jpg?subformat=icon;
	</ul>
  <no>Imported from Invenio.</no>
</reference>

</references>